Overview

Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients

Status:
Withdrawn
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to verify the equivalence in clinical efficacy of fluconazole and micafungin for the treatment of Candida bloodstream infection in non-neutropenic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Kyoto University
Collaborators:
Astellas Pharma Inc
Pfizer
Treatments:
Echinocandins
Fluconazole
Micafungin